PFS
BBP icon

Prospera Financial Services’s Virtus Biotech ETF BBP Stock Holding History

Prospera Financial Services’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-110
Closed -$5K – 1695
2022
Q1 		$5K Buy
+110
New +$4.73K ﹤0.01% 2248
2020
Q4 		– Sell
-110
Closed -$5K – 752
2020
Q3 		$5K Buy
+110
New +$5.12K ﹤0.01% 1271

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Prospera Financial Services's BBP Position: Q2 2022 in Review

Prospera Financial Services sold out of Virtus Biotech ETF (BBP) in Q2 2022, closing a stake of 110 shares — an estimated $5K sold.

Prospera Financial Services first reported a position in BBP in Q3 2020 and held it in 2 quarters. The position peaked at $5K in Q1 2022. 11 funds tracked by Wall St. Rank hold BBP as of Q2 2022.

  • Prospera Financial Services reported no remaining Virtus Biotech ETF position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 110 Virtus Biotech ETF shares in Q2 2022, an estimated $5K.
  • Prospera Financial Services first reported a position in Virtus Biotech ETF in Q3 2020 and held it in 2 quarters.
  • Prospera Financial Services's Virtus Biotech ETF position peaked at $5K in Q1 2022.
  • 11 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.